Enzyme-linked immunosorbent assays for the detection of equine antibodies specific to a recombinant Fasciola hepatica surface antigen in an endemic area
Abstract:The utility of an enzyme-linked immunosorbent assay to determine the sensitization against the trematode Fasciola hepatica in horses from an endemic area (NW Spain) was assessed. Blood samples were collected from 536 horses and tested against a 2.9-kDa recombinant surface protein (FhrAPS) to estimate the presence of IgG antibodies. Data were analysed regarding several intrinsic (age, gender and breed) and extrinsic factors (aptitude and housing). The farm size (number of horses/farm) was also considered. Sixty… Show more
“…The presence of antibodies against F. hepatica was age-related, with the lowest values in the youngest horses and the highest values in the oldest animals. These data are consistent with previous results suggesting a cumulative effect of infection throughout the life of the horse (Arias et al 2012a;Getachew et al 2010). Previous investigations in Uruguay indicate that calves exhibit the highest seroprevalence against F. hepatica crude antigens (Sanchis et al 2011).…”
Section: Discussionsupporting
confidence: 83%
“…Likewise, the highest seroprevalences were obtained among the English Pure Breed, Arab and Anglo-Arab equines from Spain (85%, 75% and 60%, respectively). However, significant differences were not observed in the seropositivity regarding the equine breed (Arias et al 2012a). It is possible that the horses are allowed access to paddocks for exercise, which may increase the risk of exposure to the metacercariae.…”
Section: Discussionmentioning
confidence: 82%
“…Because it is difficult for Fasciola to reach the adult stage in horses, the excretion of F. hepatica eggs in the faeces occurs only occasionally; therefore, the role of horses as potential trematode reservoirs has been underestimated (Arias et al 2012a). However, the delay in mature trematode development allows the immune system to stay in contact with the trematodes and antigens, thereby eliciting a strong humoral immune response (Phiri et al 2006).…”
Section: Discussionmentioning
confidence: 99%
“…The presence of IgG antibodies against the liver trematode F. hepatica was evaluated using an ELISA with the FhrAPS recombinant surface protein. The ELISA was 83% sensitive and 86% specific (Arias et al 2012a). In brief, 1 µg/ml FhrAPS was added to the wells of microtitre plates containing sera (tested in duplicate) diluted 1/100 in 10% PTL (PBS, 0.3% Tween 20 and 10% skimmed milk) and horseradish peroxidase conjugated to rabbit anti-horse IgG (Nordic Immunology Laboratories, The Netherlands) at a 1/1000 dilution.…”
Section: Methodsmentioning
confidence: 99%
“…The identification of horses exposed to F. hepatica using immunoenzymatic probes has previously been proposed (Acici et al 2013). In a recent study, an ELISA with the FhrAPS recombinant surface antigen was used to demonstrate the high seroprevalence of fasciolosis among horses feeding on grasslands formerly pastured by ruminants (Arias et al 2012a). Because horses and cattle regularly share the same pastures in Uruguay, exposure to the liver trematode in equines from this country has been evaluated in this study.…”
ABSTRACT:The risk of exposure to Fasciola hepatica in horses from Uruguay was evaluated using ELISA and a recombinant surface protein (FhrAPS). Blood samples were collected from 368 horses from different districts. Detection of antibodies and the seasonal IgG pattern against the trematode was also established. The overall seroprevalence was 54% (ranging 23% November to 93% December). Significantly higher values were observed in the Anglo-Arab horses (86%) and in those older than xix year (63%). No sex-or origin-differences were observed. Two primary risk periods for infection in Uruguay have been identified, the end of spring and autumn. Exposure to the fluke should be taken into account among those horses feeding on pastures grazed by ruminants. Using FhrAPS-ELISA, helpful information concerning the risk of horses to the infection by trematode can be obtained. This test allows the opportunity to compare the results achieved in different laboratories by minimising specific regional effects.
“…The presence of antibodies against F. hepatica was age-related, with the lowest values in the youngest horses and the highest values in the oldest animals. These data are consistent with previous results suggesting a cumulative effect of infection throughout the life of the horse (Arias et al 2012a;Getachew et al 2010). Previous investigations in Uruguay indicate that calves exhibit the highest seroprevalence against F. hepatica crude antigens (Sanchis et al 2011).…”
Section: Discussionsupporting
confidence: 83%
“…Likewise, the highest seroprevalences were obtained among the English Pure Breed, Arab and Anglo-Arab equines from Spain (85%, 75% and 60%, respectively). However, significant differences were not observed in the seropositivity regarding the equine breed (Arias et al 2012a). It is possible that the horses are allowed access to paddocks for exercise, which may increase the risk of exposure to the metacercariae.…”
Section: Discussionmentioning
confidence: 82%
“…Because it is difficult for Fasciola to reach the adult stage in horses, the excretion of F. hepatica eggs in the faeces occurs only occasionally; therefore, the role of horses as potential trematode reservoirs has been underestimated (Arias et al 2012a). However, the delay in mature trematode development allows the immune system to stay in contact with the trematodes and antigens, thereby eliciting a strong humoral immune response (Phiri et al 2006).…”
Section: Discussionmentioning
confidence: 99%
“…The presence of IgG antibodies against the liver trematode F. hepatica was evaluated using an ELISA with the FhrAPS recombinant surface protein. The ELISA was 83% sensitive and 86% specific (Arias et al 2012a). In brief, 1 µg/ml FhrAPS was added to the wells of microtitre plates containing sera (tested in duplicate) diluted 1/100 in 10% PTL (PBS, 0.3% Tween 20 and 10% skimmed milk) and horseradish peroxidase conjugated to rabbit anti-horse IgG (Nordic Immunology Laboratories, The Netherlands) at a 1/1000 dilution.…”
Section: Methodsmentioning
confidence: 99%
“…The identification of horses exposed to F. hepatica using immunoenzymatic probes has previously been proposed (Acici et al 2013). In a recent study, an ELISA with the FhrAPS recombinant surface antigen was used to demonstrate the high seroprevalence of fasciolosis among horses feeding on grasslands formerly pastured by ruminants (Arias et al 2012a). Because horses and cattle regularly share the same pastures in Uruguay, exposure to the liver trematode in equines from this country has been evaluated in this study.…”
ABSTRACT:The risk of exposure to Fasciola hepatica in horses from Uruguay was evaluated using ELISA and a recombinant surface protein (FhrAPS). Blood samples were collected from 368 horses from different districts. Detection of antibodies and the seasonal IgG pattern against the trematode was also established. The overall seroprevalence was 54% (ranging 23% November to 93% December). Significantly higher values were observed in the Anglo-Arab horses (86%) and in those older than xix year (63%). No sex-or origin-differences were observed. Two primary risk periods for infection in Uruguay have been identified, the end of spring and autumn. Exposure to the fluke should be taken into account among those horses feeding on pastures grazed by ruminants. Using FhrAPS-ELISA, helpful information concerning the risk of horses to the infection by trematode can be obtained. This test allows the opportunity to compare the results achieved in different laboratories by minimising specific regional effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.